- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 178 results
In the News · Source: The New York Times
April 22, 2026
David Farber discusses how the arbitration process established by the No Surprises Act is affecting those who serve as arbitrators
In the News · Source: Law.com
March 19, 2026
Liv Kiser represents Dave's Killer Bread in a class action settlement regarding a mislabeling dispute
In the News · Source: Law360 and The AmLaw Litigation Daily
In the News · Source: Law.com
In the News · Source: Pink Sheet
February 3, 2026
Heather Bañuelos discusses the FDA increasingly citing promotional claims based on time-to-event endpoint data from single-arm trials
In the News · Source: Bloomberg Law
In the News · Source: Managed Healthcare Executive
January 19, 2026
John Shakow and David Farber comment on the limitations of rebates and cost savings for health plans and patients under new Medicare drug programs
In the News · Source: Law360 Healthcare Authority
January 13, 2026
Lauren Roth provides analysis regarding the decrease in FDA guidance during President Trump's administration
In the News · Source: Law360 Healthcare Authority
December 2, 2025
Lauren Roth comments on the Food and Drug Administration’s uptick of pilot programs launched this year
In the News · Source: PharmaCircle
Recognition
November 18, 2025
King & Spalding’s German Banking & Finance Team and Partner Ulf Grundmann Named as Finalists for 2026 Legal 500 Germany Awards
In the News · Source: STAT
November 4, 2025
David Farber explains why the expansion of telehealth has driven the increase in compounding in recent years